A hybrid phase I‐II/III clinical trial design allowing dose re‐optimization in phase III (Q5214489)
From MaRDI portal
scientific article; zbMATH DE number 7165177
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A hybrid phase I‐II/III clinical trial design allowing dose re‐optimization in phase III |
scientific article; zbMATH DE number 7165177 |
Statements
A hybrid phase I‐II/III clinical trial design allowing dose re‐optimization in phase III (English)
0 references
7 February 2020
0 references
Bayesian design
0 references
clinical trial
0 references
dose finding
0 references
phase I-II clinical trial
0 references
phase III clinical trial
0 references
